Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Pharma
J&J chief Joaquin Duato collects sizable pay raise for 2025
J&J CEO Joaquin Duato has scored $32.8 million in 2025 pay, marking a significant leap over the $24.3 million he received for 2024.
Fraiser Kansteiner
Mar 11, 2026 10:55am
Super Bowl, Olympics defined TV drug ad spending in February
Mar 6, 2026 12:39pm
FDA untitled letter lambastes claims in ad for J&J's Tremfya
Feb 19, 2026 11:04am
J&J's Tremfya roars into 2026 with massive January TV ad spend
Feb 11, 2026 12:33pm
AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition
Feb 4, 2026 2:52pm
J&J expects revenue to reach $100B in 2026 amid Darzalex surge
Jan 21, 2026 12:01pm